BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20585861)

  • 21. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy.
    Barison A; Del Torto A; Chiappino S; Aquaro GD; Todiere G; Vergaro G; Passino C; Lombardi M; Emdin M; Masci PG
    J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):681-7. PubMed ID: 26090916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of myocardial fibrosis on left ventricular torsion and twist in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T; Gürel E; Tigen K; Güler A; Dündar C; Fotbolcu H; Basaran Y
    Cardiol J; 2013; 20(3):276-86. PubMed ID: 23788302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy.
    Psaltis PJ; Carbone A; Nelson AJ; Lau DH; Jantzen T; Manavis J; Williams K; Itescu S; Sanders P; Gronthos S; Zannettino AC; Worthley SG
    JACC Cardiovasc Interv; 2010 Sep; 3(9):974-83. PubMed ID: 20850099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy.
    Samady H; Liu YH; Choi CJ; Ragosta M; Pfau SE; Cleman MW; Powers ER; Kramer CM; Wackers FJ; Beller GA; Watson DD
    Am J Cardiol; 2003 Apr; 91(7):807-11. PubMed ID: 12667565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
    Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
    Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of non-ischemic dilated cardiomyopathy with T1 mapping and ECV methods using 3T cardiac MRI.
    Görmeli CA; Özdemir ZM; Kahraman AS; Yağmur J; Özdemir R; Çolak C
    Radiol Med; 2017 Feb; 122(2):106-112. PubMed ID: 27785679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse fibrosis leads to a decrease in unipolar voltage: Validation in a swine model of premature ventricular contraction-induced cardiomyopathy.
    Tanaka Y; Rahmutula D; Duggirala S; Nazer B; Fang Q; Olgin J; Sievers R; Gerstenfeld EP
    Heart Rhythm; 2016 Feb; 13(2):547-54. PubMed ID: 26416621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Area of left ventricular regional conduction delay and preserved myocardium predict responses to cardiac resynchronization therapy.
    Tse HF; Lee KL; Wan SH; Yu Y; Hoersch W; Pastore J; Zhu Q; Kenknight B; Spinelli J; Lau CP
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):690-5. PubMed ID: 16050824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement.
    Nanjo S; Yoshikawa K; Harada M; Inoue Y; Namiki A; Nakano H; Yamazaki J
    Circ J; 2009 Oct; 73(10):1939-44. PubMed ID: 19729860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.
    Psaltis PJ; Worthley SG
    J Cardiovasc Transl Res; 2009 Mar; 2(1):48-62. PubMed ID: 20559969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy.
    Puntmann VO; Arroyo Ucar E; Hinojar Baydes R; Ngah NB; Kuo YS; Dabir D; Macmillan A; Cummins C; Higgins DM; Gaddum N; Chowienczyk P; Plein S; Carr-White G; Nagel E
    Hypertension; 2014 Oct; 64(4):762-8. PubMed ID: 25024285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial work is associated with significant left ventricular myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Gonçalves AV; Rosa SA; Branco L; Galrinho A; Fiarresga A; Lopes LR; Thomas B; Baquero L; Carmo MM; Ferreira RC
    Int J Cardiovasc Imaging; 2021 Jul; 37(7):2237-2244. PubMed ID: 33598850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration.
    Toyoda Y; Okada M; Kashem MA
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1367-73. PubMed ID: 9628680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.
    Al-Wakeel-Marquard N; Seidel F; Herbst C; Kühnisch J; Kuehne T; Berger F; Klaassen S; Messroghli DR
    Int J Cardiol; 2021 Jun; 333():219-225. PubMed ID: 33737165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.